ScripInovio Pharmaceuticals, Inc. announced it is changing course with its COVID-19 vaccine in an effort to develop it as a booster shot as the pandemic transitions to an endemic, while also announcing a
Pink SheetAn accelerated approval for Zydus Cadila ’s COVID-19 vaccine from India's regulator has given the company global bragging rights to the first plasmid DNA vaccine for use in humans. Zy-CoV-D also beco
ScripZydus Cadila ’s application to the Indian regulator for an accelerated nod or emergency use authorization (EUA) for its COVID-19 vaccine takes the world a step closer to the first plasmid DNA vaccine
ScripInovio Shifts Vaccine Focus Elsewhere As US Trial Funding Ends Inovio Pharmaceuticals, Inc. will focus Phase III development of its DNA vaccine INO-4800 outside the US now that US funding has ended